Antimetabolite Immunosuppressant [EPC]

8676 reported adverse events

Drugs of this class: MYCOPHENILIC ACID MYCOPHENOLIC ACID

These side effects are most commonly reported by patients taking drugs of the Antimetabolite Immunosuppressant [EPC] class:

# Side effect Count
0 OFF LABEL USE 889
1 DRUG INEFFECTIVE 471
2 PRODUCT USE IN UNAPPROVED INDICATION 434
3 DIARRHOEA 411
4 ACUTE KIDNEY INJURY 410
5 COVID-19 381
6 CYTOMEGALOVIRUS INFECTION 374
7 DRUG INTERACTION 336
8 PYREXIA 325
9 NEUTROPENIA 270
See all common reactions for Antimetabolite Immunosuppressant [EPC]

Drugs of the Antimetabolite Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AORTIC PSEUDOANEURYSM 6 0.3158
1 HISTOPLASMOSIS CUTANEOUS 7 0.2917
2 DIABETIC MACROANGIOPATHY 8 0.2759
3 CUTANEOUS MALACOPLAKIA 7 0.2593
4 ANORECTAL VARICES 6 0.2308
5 NEW ONSET DIABETES AFTER TRANSPLANTATION 8 0.1702
6 MALACOPLAKIA GASTROINTESTINAL 11 0.1692
7 GASTROINTESTINAL MUCORMYCOSIS 11 0.1692
8 PASSENGER LYMPHOCYTE SYNDROME 6 0.1667
9 RHODOCOCCUS INFECTION 17 0.1650
See all enriched reactions for Antimetabolite Immunosuppressant [EPC]